scholarly journals Effect of niche components on masseter satellite cell differentiation on fibrin coatings

Author(s):  
Olivier Willem Lijten ◽  
Doris Haydee Rosero Salazar ◽  
Merijn Erp ◽  
Ewald Bronkhorst ◽  
Johannes W. Von den Hoff
2004 ◽  
Vol 231 (3) ◽  
pp. 489-502 ◽  
Author(s):  
Orna Halevy ◽  
Yogev Piestun ◽  
Mohammed Z. Allouh ◽  
Benjamin W.C. Rosser ◽  
Yuval Rinkevich ◽  
...  

2016 ◽  
Vol 120 (12) ◽  
pp. 1381-1393 ◽  
Author(s):  
Ratchakrit Srikuea ◽  
Muthita Hirunsai

The recent discovery of the vitamin D receptor (VDR) in regenerating muscle raises the question regarding the action of vitamin D3 on skeletal muscle regeneration. To investigate the action of vitamin D3 on this process, the tibialis anterior muscle of male C57BL/6 mice (10 wk of age) was injected with 1.2% BaCl2 to induce extensive muscle injury. The bioactive form of vitamin D3 [1α,25(OH)2D3] was administered daily via intramuscular injections during the regenerative phase (days 4-7 postinjury). Physiological and supraphysiological doses of 1α,25(OH)2D3 relative to 1 μg/kg muscle wet weight and mouse body weight were investigated. Muscle samples were collected on day 8 postinjury to examine proteins related to vitamin D3 metabolism (VDR, CYP24A1, and CYP27B1), satellite cell differentiation and regenerative muscle fiber formation [myogenin and embryonic myosin heavy chain (EbMHC)], protein synthesis signaling (Akt, p70 S6K1, 4E-BP1, and myostatin), fiber-type composition (fast and slow MHCs), fibrous formation (vimentin), and angiogenesis (CD31). Administration of 1α,25(OH)2D3 at physiological and supraphysiological doses enhanced VDR expression in regenerative muscle. Moreover, CYP24A1 and vimentin expression was increased, accompanying decreased myogenin and EbMHC expression at the supraphysiological dose. However, there was no change in CYP27B1, Akt, p70 S6K1, 4E-BP1, myostatin, fast and slow MHCs, or CD31 expression at any dose investigated. Taken together, administration of 1α,25(OH)2D3 at a supraphysiological dose decreased satellite cell differentiation, delayed regenerative muscle fiber formation, and increased muscular fibrosis. However, protein synthesis signaling, fiber-type composition, and angiogenesis were not affected by either 1α,25(OH)2D3 administration at a physiological or supraphysiological dose.


2018 ◽  
Vol 42 (5) ◽  
pp. 525-532 ◽  
Author(s):  
Chang Liu ◽  
Huili Tong ◽  
Shufeng Li ◽  
Yunqin Yan

Stem Cells ◽  
2014 ◽  
Vol 32 (6) ◽  
pp. 1661-1673 ◽  
Author(s):  
Lizhe Zhuang ◽  
Julie-Ann Hulin ◽  
Anastasia Gromova ◽  
Thi Diem Tran Nguyen ◽  
Ruth T. Yu ◽  
...  

2002 ◽  
Vol 22 (4) ◽  
pp. 1140-1149 ◽  
Author(s):  
Yuri V. Fedorov ◽  
Nathan C. Jones ◽  
Bradley B. Olwin

ABSTRACT Oncogenic Ha-Ras is a potent inhibitor of skeletal muscle cell differentiation, yet the Ras effector mediating this process remains unidentified. Here we demonstrate that the atypical protein kinases (aPKCs; λ and/or ζ) are downstream Ras effectors responsible for Ras-dependent inhibition of myogenic differentiation in a satellite cell line. First, ectopic expression of Ha-RasG12V induces translocation of PKCλ from the cytosol to the nucleus, suggesting that aPKCs are activated by Ras in myoblasts. The aPKCs function as downstream Ras effectors since inhibition of aPKCs by expression of a dominant negative PKCζ mutant or by treatment of cells with an inhibitor, GO6983, promotes myogenesis in skeletal muscle satellite cells expressing oncogenic Ha-Ras. Arresting cell proliferation synergistically enhances myogenic differentiation only when aPKCs are also inhibited. Thus, the repression of myogenic differentiation in a satellite cell line appears to be directly mediated by aPKCs acting as Ras effectors and indirectly mediated via stimulation of cell proliferation.


2011 ◽  
Vol 25 (6) ◽  
pp. 1914-1921 ◽  
Author(s):  
Huijie Liu ◽  
Airu Niu ◽  
Shuen‐Ei Chen ◽  
Yi‐Ping Li

Sign in / Sign up

Export Citation Format

Share Document